GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (NAS:OPK) » Definitions » Cyclically Adjusted PS Ratio

OPKO Health (OPKO Health) Cyclically Adjusted PS Ratio : 0.68 (As of Apr. 28, 2024)


View and export this data going back to 1995. Start your Free Trial

What is OPKO Health Cyclically Adjusted PS Ratio?

As of today (2024-04-28), OPKO Health's current share price is $1.26. OPKO Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $1.86. OPKO Health's Cyclically Adjusted PS Ratio for today is 0.68.

The historical rank and industry rank for OPKO Health's Cyclically Adjusted PS Ratio or its related term are showing as below:

OPK' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.48   Med: 4.94   Max: 118.53
Current: 0.68

During the past years, OPKO Health's highest Cyclically Adjusted PS Ratio was 118.53. The lowest was 0.48. And the median was 4.94.

OPK's Cyclically Adjusted PS Ratio is ranked better than
80% of 135 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.21 vs OPK: 0.68

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

OPKO Health's adjusted revenue per share data for the three months ended in Dec. 2023 was $0.242. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $1.86 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


OPKO Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for OPKO Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Cyclically Adjusted PS Ratio Chart

OPKO Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.58 3.43 3.21 0.73 0.81

OPKO Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.83 1.20 0.87 0.81

Competitive Comparison of OPKO Health's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, OPKO Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where OPKO Health's Cyclically Adjusted PS Ratio falls into.



OPKO Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

OPKO Health's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1.26/1.86
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, OPKO Health's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.242/129.4194*129.4194
=0.242

Current CPI (Dec. 2023) = 129.4194.

OPKO Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.054 99.695 0.070
201406 0.057 100.560 0.073
201409 0.046 100.428 0.059
201412 0.059 99.070 0.077
201503 0.067 99.621 0.087
201506 0.092 100.684 0.118
201509 0.277 100.392 0.357
201512 0.509 99.792 0.660
201603 0.533 100.470 0.687
201606 0.641 101.688 0.816
201609 0.540 101.861 0.686
201612 0.297 101.863 0.377
201703 0.477 102.862 0.600
201706 0.519 103.349 0.650
201709 0.440 104.136 0.547
201712 0.288 104.011 0.358
201803 0.456 105.290 0.561
201806 0.471 106.317 0.573
201809 0.446 106.507 0.542
201812 0.387 105.998 0.473
201903 0.379 107.251 0.457
201906 0.386 108.070 0.462
201909 0.390 108.329 0.466
201912 0.360 108.420 0.430
202003 0.330 108.902 0.392
202006 0.470 108.767 0.559
202009 0.668 109.815 0.787
202012 0.772 109.897 0.909
202103 0.851 111.754 0.986
202106 0.684 114.631 0.772
202109 0.592 115.734 0.662
202112 0.615 117.630 0.677
202203 0.499 121.301 0.532
202206 0.435 125.017 0.450
202209 0.240 125.227 0.248
202212 0.247 125.222 0.255
202303 0.316 127.348 0.321
202306 0.353 128.729 0.355
202309 0.238 129.860 0.237
202312 0.242 129.419 0.242

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OPKO Health  (NAS:OPK) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


OPKO Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of OPKO Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OPKO Health (OPKO Health) Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.
Executives
Frost Phillip Md Et Al 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Hsiao Jane Ph D director 4400 BISCAYNE BLVD, MIAMI FL 33137
Gary J. Nabel director, officer: Chief Innovation Officer C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Elias A. Zerhouni director, officer: Vice Chairman and President 2099 PENNSYLVANIA AVENUE, NW 12TH FLOOR, WASHINGTON DC 20006
John A Paganelli director, other: Chairman of the Board OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Steven D Rubin director OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Pfenniger Richard C Jr director 4400 BISCAYNE BLVD., MIAMI FL 33137
Alexis Borisy director C/O COMBINATORX, INCORPORATED, 245 FIRST STREET, 16TH FLOOR, CAMBRIDGE MA 02142
Jon R Cohen director, officer: SVP OPKO; Exec Chairman BRLI C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Prem A Lachman director 4400 BISCAYNE BLVD., MIAMI FL 33137
Roger Md Medel director 1301 CONCORD TERRACE, SUNRISE FL 33323
Rulfo Fernando Hernandez officer: CAO, Treasurer C/O OPKO HEALTH INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Anthony J Japour director 19805 N. CREEK PARKWAY, BOTHELL WA 98011
Robert Scott Fishel director C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Adam Logal officer: Exec.Dir .of Fin., CAO,Treas. OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137